Boston biotech launches organ-chip tech as FDA moves away from animal tests June 10, 2025July 9, 2025 Share More from the Blog A Regulatory Turning Point: A Recent Timeline of U.S. Actions to Reduce and Replace Animal Models in Preclinical Research Read More Using Organs-On-Chips to Evaluate On-Target/Off-Tumor Effects of Cancer Immunotherapies Read More Developing More Clinically Relevant Drug-Induced Thrombosis Models Read More Browse All
